Skip to main content

Table 6 Proviral load for each HLA-A allele and clinical status

From: HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina

Allele

Population

Mean PVL

AC

ATLL

HAM

HLA-A*02

1.42

12.49*

4.35

3.13

HLA-A*03

4.61*

–

–

4.61

HLA-A*11

–

–

4.03*

4.03

HLA-A*23

–

0.34*

–

0.34

HLA-A*24

6.64

0.34*

–

4.54

HLA-A*25

1.29*

–

–

1.29

HLA-A*26

1.29*

–

–

1.29

HLA-A*29

–

–

9.32**

9.32

HLA-A*31

1.29

33.98

15.1

12.28

HLA-A*32

–

9.82*

–

9.82

HLA-A*33

1.85**

40.2*

11.12

12.88

HLA-A*68

4.61*

1.3*

–

2.95

HLA-A*69

ND

–

–

ND

  1. AC asymptomatics carriers, HAM HTLV-1 associated myelopathy, ATLL Adult T cell leukemia/lymphoma, NII Non-infected Individuals, HLA Human leukocyte antigen, PVL proviral load
  2. *Only the PVL of one allele was available, **Mean PVL of two alleles
Back to article page

Retrovirology

ISSN: 1742-4690

Contact us